Animal models of ejaculatory behavior

Current Pharmaceutical Design

Volumn 11, Issue 31, 2005, Pages 4069-4077

  Pattij, T ^a,b   Olivier, B ^a,c   Waldinger, M D ^a,d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LEYENBURG HOSPITAL   (Netherlands)

Author keywords

Animal model; Premature ejaculation; Serotonine; SSRI

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ANPIRTOLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; FG 5893; FLESINOXAN; FLUOXETINE; GEPIRONE; IDAZOXAN; IPSAPIRONE; MELATONIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; OXYTOCIN; PAROXETINE; PRAMIPEXOLE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; SND 5893; UNCLASSIFIED DRUG; YOHIMBINE;

DISEASE MODEL; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; DRUG TOXICITY; EJACULATION; EJACULATION DISORDER; EXPERIMENTAL ANIMAL; MALE; NEUROANATOMY; NEUROBIOLOGY; NONHUMAN; PREMATURE EJACULATION; PRIORITY JOURNAL; PSYCHOGENESIS; PSYCHOSEXUAL DISORDER; REVIEW; SEROTONINERGIC SYSTEM; SEXUAL BEHAVIOR;

ANIMALS; DISEASE MODELS, ANIMAL; EJACULATION; HUMANS; MALE; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEXUAL BEHAVIOR, ANIMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 27944444916     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161205774913363     Document Type: Review

References (85)

1. Waldinger MD. Lifelong premature ejaculation: from authority based to evidence based medicine. Brit J Urol Internat 2004; 93: 201-207.
2. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. J Impot Res 2004; 16: 369-381.
3. Althof SE, Levine SB, Corty EW, Risen CB, Stern EB, Kurit DM. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402-407.
4. Kara H, Aydin S, Agargun Y, Odabas O, Yilmiz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind, placebo controlled study. J Urol 1996; 156: 1631-1632.
5. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998; 18: 274-281.
6. Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomized, placebo-controlled, fixed-dose study with paroxetine, sertraline, and nefazodone. J Clin Psychopharmacol 2001; 21: 293-297.
7. Waldinger MD, Zwinderman AH, Olivier B. SSRIs and ejaculation: a double-blind, randomised, fixed-dose study with paroxetine and citalopram. J Clin Psychopharmacol 2001; 21: 556-560.
8. Waldinger MD, Zwinderman AH, Olivier B. Antidepressants and ejaculation: a double-blind, randomised, fixed-dose study with mirtazapine and paroxetine. J Clin Psychopharmacol 2003; 23: 448-50.
9. Novaretti JPT, Pompeo ACL, Arap S. Selective serotonin uptake inhibitor in the treatment of premature ejaculation. Braz J Urol 2002; 28: 116-122.
10. Atmaca M, Kuloglu M, Tezcan E, Semercioz A. The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int J Impot Res 2002; 14; 502-505.
11. Waldinger MD, vd Plas A, Pattij T, v Oorschot R, Coolen LM, Veening JG, et al. The SSRIs fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 2001; 160: 283-289.
12. Waldinger MD, Berendsen HHG, Blok BFM, Olivier B, Holstege G. Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111-118.
13. Waldinger MD, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13 (suppl 6): S27-S33.
14. Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol 1998; 13 (suppl 6): S9-14.
15. Waldinger MD, Olivier B. In: Sacchetti E, Spano P Eds, Advances in preclinical and clinical psychiatry, vol I: fluvoxamine: established and emerging roles in psychiatric disorders. Milan, Excerpta Medica 2000; 117-130.
16. Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet 1998; 8: 37-40.
17. Waldinger MD. The neurobiological approach to premature ejaculation (review article). J Urol 2002; 168: 2359-2367.
18. Waldinger MD. In: Levine SB, Risen CB, Althof SE Eds, Handbook of clinical sexuality for mental health professionals. New York, Brunner-Routledge 2003; 257-274.
19. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomised, placebo-controlled study. Am J Psychiatry 1994; 151: 1377-1379.
20. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res 2003; 15: 309-313.
21. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Practice 1998; 2: 287-293.
22. Larsson K, Ahlenius S. Brain and sexual behavior. Ann NY Acad Sci 1999; 877: 292-308.
23. Pfaus JG. Neurobiology of sexual behavior. Curr Opin Neurobiol 1999; 9: 751-758.
24. Agmo A. Sexual motivation - an inquiry into events determining the occurrence of sexual behavior. Behav Brain Res 1999; 105: 129-150.
25. Pfaus JG, Heeb MM. Implications of immediate-early gene induction in the brain following sexual stimulation of female and male rodents. Brain Res Bull 1997; 44: 397-407.
26. Veening JG, Coolen LM. Neural activation following sexual behavior in the male and female rat brain. Behav Brain Res 1998; 92: 181-193.
27. Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science 2002; 297: 1566-1569.
28. Truitt WA, Shipley MT, Veening JG, Coolen LM. Activation of a subset of lumbar spinothalamic neurons after copulatory behavior in male but not female rats. J Neurosci 2003; 23: 325-3
29. Bitran D, Hull EM. Pharmacological analyis of male rat sexual behavior. Neurosci Biobehav Rev 1987; 11: 365-389.
30. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995; 19: 19-38.
31. Hull EM, Lorrain DS, Du J, Matuszewich L, Lumley LA, Putnam SK, et al. Hormone-neurotransmitter interactions in the control of sexual behavior. Behav Brain Res 1999; 105: 105-116.
32. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46: 157-203.
33. 1 autoreceptors: parallel purposes or pointless plurality? Trends Neurosci 2000; 23: 459-465.
34. Albinsson A, Andersson G, Andersson K, VegaMatuszczyk J, Larsson K. The effects of lesions in the mesencephalic raphe systems on male rat sexual behavior and locomotor activity. Behav Brain Res 1996; 80: 57-63.
35. Tagliamonte A, Tagliamonte P, Gessa GL, Brodie BB. Compulsive sexual activity induced by p-chlorophenylalanine in normal and pinealectomized male rats. Science 1969; 166: 1433-1435.
36. Ahlenius S, Larsson K, Svensson L. Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior. Psychopharmacology 1980; 68: 217-220.
37. Dornan WA, Katz JL, Ricaurte GA. The effects of repeated administration of MDMA on the expression of sexual behavior in the male rat. Pharmacol Biochem Behav 1991; 39: 813-8
38. Foreman MM, Hall JL, Love RL. Effects of fenfluramine and parachloroamphetamine on sexual behavior of male rats. Psychopharmacology 1992; 107: 327-330.
39. Gonzales G, Mendoza L, Ruiz J, Torrejon J. A demonstration that 5-hydroxytryptamine administered peripherally can affect sexual behavior in male rats. Life Sci 1982; 31: 2775-2781.
40. Bago M, Marson L, Dean C. Serotonergic projections to the rostroventrolateral medulla from midbrain and raphe nuclei. Brain Res 2002; 945: 249-258.
41. Hermann GE, Holmes GM, Rogers RC, Beattie MS, Bresnahan JC. Descending projections from the rostral gigantocellular reticular nuclei complex. J Comp Neurol 2003; 455: 210-221.
42. Johnson RD, Hubscher CH. Brainstem microstimulation differentially inhibits pudendal motoneuron reflex inputs. Neuroreport 1998; 9: 341-345.
43. Mos J, Mollet I, Tolboom JTBM, Waldinger MD, Olivier B. A comparison of the effects of different serotonin reuptake blockers on sexual behaviour of the male rat. Eur Neuropsychopharmacol 1999; 9: 123-135.
44. 1A antagonist WAY-100635 and citalopram on male rat ejaculatory behavior. Eur J Pharmacol 1999; 379: 1-6.
45. Matuszcyk JV, Larsson K, Eriksson E. The selective serotonin reuptake inhibitor fluoxetine reduces sexual motivation in male rats. Pharmacol Biochem Behav 1998; 60: 527-532.
46. Cantor J, Binik I, Pfaus JG. Chronic fluoxetine inhibits sexual behavior in the male rat: reversal with oxytocin. Psychopharmacology 1999; 144: 355-362.
47. Frank JL, Hendricks SE, Olson CH. Multiple ejaculations and chronic fluoxetine: effects on male rat copulatory behavior. Pharmacol Biochem Behav 2000; 66: 337-342.
48. 1A receptors. J Neurosci 1998; 18: 10150-10156.
49. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 2000; 39: 110-122.
50. 1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-1. Br J Pharmacol 1998; 125: 1733-1743.
51. Argiolas A. Neuropeptides and sexual behaviour. Neurosci Biobehav Rev 1999; 23: 1127-1142.
52. 1A receptor agonist. J Pharmacol Exp Ther 1996; 279: 1035-1042.
53. 1A receptors. J Pharmacol Exp Ther 1997; 282: 1581-1590.
54. 2 antagonist by attenuating DOI-induced inhibition of male rat sexual behaviour. Psychopharmacology 1995; 119: 291-294.
55. 1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology 1998; 137: 374-382.
56. 2 receptor antagonist amperozide attenuates 1-(2, 5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. Eur J Pharmacol 1992; 212: 241-246.
57. 2 antagonists. Pharmacol Biochem Behav 1991; 39: 605-621.
58. 3 antagonists and benzodiazepines: their comparative behavioural pharmacology. Chichester, John Wiley and Sons 1990; 281-315.
59. 2 antagonistic properties, on male-rat sexual-behavior. Eur J Pharmacol 1994; 255: 131-137.
60. Haensel SM, Slob AK. Flesinoxan: a prosexual drug for male rats. Eur J Pharmacol 1997; 330: 1-9.
61. Mos J, Van Logten J, Bloetjes K, Olivier B. The effects of idazoxan and 8-OH-DPAT on sexual behaviour and associated ultrasonic vocalizations in the rat. Neurosci Biobehav Rev 1991;15: 505-515.
62. 1A, antagonist. Brain Res 1999; 820: 55-62.
63. Beach FA. Comparison of copulatory behavior of male rats raised in isolation, cohabitation, and segregation. J Genet Psych 1942; 60: 3-13.
64. Mos J, Olivier B, Bloetjes K, Poth M. In: Slob AK, Baum MJ Eds, Psychoneuroendocrinology of growth and development. Rotterdam, Medicom Publishers 1990; 221-232.
65. Gessa GL, Paglietti E, Pellegrini-Quarantotti B. Induction of copulatory behaviour in sexual inactive rats by naloxone. Science 1979; 204: 203-205.
66. Haensel SM, Mos J, Olivier B, Slob AK. Sex behavior of male and female wistar rats affected by the serotonin agonist 8-OH-DPAT. Pharmacol Biochem Behav 1991; 40: 221-228.
67. Giuliani D, Ottani A, Ferrari F. Influence of sildanefil on copulatory behaviour in sluggish or normal ejaculator rats: a central dopamine mediated effect? Neuropharmacology 2002; 42: 562-5
68. Ottani A, Giuliani D, Ferrari F. Modulatory activity of sildanefil on copulatory behaviour of both intact and castrated male rats. Pharmacol Biochem Behav 2002; 72: 717-722.
69. Drago F, Busa L. Acute low doses of melatonin restore full sexual activity in impotent male rats. Brain Res 2000; 878: 98-104.
70. Swanson LW, Kuypers HG. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J Comp Neurol 1980; 194: 555-570.
71. Arletti R, Calza L, Giardino L, Benelli A, Cavazzuti E, Bertolini A. Sexual impotence is associated with a reduced production of oxytocin and with an increased production of opioid peptides in the paraventricular nucleus of male rats. Neurosci Lett 1997; 233: 65-68.
72. Pfaus JG, Gorzalka BB. Opioids and sexual behaviour. Neurosci Biobehav Rev 1987; 11: 1-34.
73. Rodriguez-Manzo G, Asai M, Fernandez-Guasti A. Evidence for changes in brain enkephalin contents associated to male rat sexual activity. Behav Brain Res 2002; 131: 47-55.
74. Ferrari F, Giuliani D. The selective D-2 dopamine-receptor antagonist eticlopride counteracts the ejaculatio-praecox induced by the selective D-2-dopamine agonist SND-919 in the rat. Life Sci 1994; 55: 1155-1162.
75. Barfield RJ, Sachs BD. Sexual behavior: stimulation by painful electrical shock to skin in male rats. Science 1968; 161: 392-395.
76. Wang L, Hull EM. Tail pinch induces sexual behavior in olfactory bulbectomized male rats. Physiol Behav 1980; 24: 211-215.
77. Leyton M, Stewart J. Acute and repeated activation of male sexual behavior by tail pinch: opioid and dopaminergic mechanisms. Physiol Behav 1996; 60: 77-85.
78. Rowland DL. Penile sensitivity in men: a composite of recent findings. Urology 1998; 52: 1101-1105.
79. Homberg JR, Van den Akker M, Raaso HS, Wardeh G, Binnekade R, Schoffelmeer ANM, et al. Enhanced motivation to self-administer cocaine is predicted by self-grooming behaviour and relates to dopamine release in the rat medial prefrontal cortex and amygdala. Eur J Neurosci 2002, 15: 1542-15
80. Ellenbroek BA, Cools AR. Apomorphine susceptibility and animal models for psychopathology: genes and environment. Behav Genet 2002; 32: 349-361.
81. Sluyter F, Van Oortmerssen GA, De Ruiter AJH, Koolhaas JM. Aggression in wild house mice: current state of affairs. Behav Genet 1996; 26: 489-496.
82. 1A receptor sensitivity: behavioral and functional correlates. Psychiatr Genet 1996; 6: 107-1.
83. McCann SM, Haens G, Mastronardi C, Walczewska A, Karanth S, Rettori V, et al. The role of nitric oxide (NO) in control of LHRH release that mediates gonadotropin release and sexual behavior. Curr Pharm Design 2003; 9(5): 381-90.
84. Messer WS Jr. Bivalent ligands for G protein-coupled receptors. Curr Pharm Design 2004; 10(17): 2015-20.
85. Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Design 2004; 10(20): 2463-75.